Dr. Chris Bahl Appointed CEO of AI Proteins
Key Highlights Dr. Chris Bahl, founder and President, now appointed as CEO of AI Proteins. Brings expertise in…
Browsing Tag
Memorial Sloan Kettering Cancer Center
4 posts
Carta Healthcare Expands AI Platform with Realyze Intelligence Acquisition
Key Highlights Carta Healthcare acquires Realyze Intelligence to enhance its AI capabilities and drive clinical trial matching. Realyze Intelligence’s AI…
Samuel Bakhoum Appointed Chief Scientific Officer at Volastra Therapeutics
Key Highlights Samuel Bakhoum, co-founder, named Chief Scientific Officer at Volastra Therapeutics. Dr. Bakhoum joins from Memorial Sloan Kettering, known…
Paige Unveils Strategic Shift to Advance AI in Cancer Care
Key Highlights Paige transitions its AI solutions to a standalone offering compatible with other digital pathology platforms. Razik…